nodes	percent_of_prediction	percent_of_DWPC	metapath
Rescinnamine—ACE—type 2 diabetes mellitus	0.37	1	CbGaD
Rescinnamine—ACE—Ramipril—type 2 diabetes mellitus	0.252	0.629	CbGbCtD
Rescinnamine—ACE—Losartan—type 2 diabetes mellitus	0.149	0.371	CbGbCtD
Rescinnamine—ACE—arteriole—type 2 diabetes mellitus	0.011	0.175	CbGeAlD
Rescinnamine—ACE—forelimb zeugopod—type 2 diabetes mellitus	0.00962	0.154	CbGeAlD
Rescinnamine—ACE—tunica intima—type 2 diabetes mellitus	0.0078	0.125	CbGeAlD
Rescinnamine—ACE—sympathetic nervous system—type 2 diabetes mellitus	0.007	0.112	CbGeAlD
Rescinnamine—ACE—autonomic nervous system—type 2 diabetes mellitus	0.00471	0.0752	CbGeAlD
Rescinnamine—ACE—hindlimb—type 2 diabetes mellitus	0.00435	0.0695	CbGeAlD
Rescinnamine—ACE—peripheral nervous system—type 2 diabetes mellitus	0.00339	0.0542	CbGeAlD
Rescinnamine—ACE—artery—type 2 diabetes mellitus	0.00267	0.0426	CbGeAlD
Rescinnamine—ACE—nerve—type 2 diabetes mellitus	0.00265	0.0423	CbGeAlD
Rescinnamine—SLC18A2—Dopaminergic Neurogenesis—NKX6-1—type 2 diabetes mellitus	0.00238	0.0648	CbGpPWpGaD
Rescinnamine—ACE—endothelium—type 2 diabetes mellitus	0.00225	0.036	CbGeAlD
Rescinnamine—SLC18A2—Dopaminergic Neurogenesis—NEUROD1—type 2 diabetes mellitus	0.00221	0.0602	CbGpPWpGaD
Rescinnamine—ACE—ACE Inhibitor Pathway—AGTR2—type 2 diabetes mellitus	0.00197	0.0537	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—PCSK2—type 2 diabetes mellitus	0.00192	0.0523	CbGpPWpGaD
Rescinnamine—SLC18A2—adipose tissue—type 2 diabetes mellitus	0.0012	0.0191	CbGeAlD
Rescinnamine—SLC18A2—Dopamine Neurotransmitter Release Cycle—SNAP25—type 2 diabetes mellitus	0.00116	0.0315	CbGpPWpGaD
Rescinnamine—SLC18A2—Norepinephrine Neurotransmitter Release Cycle—SNAP25—type 2 diabetes mellitus	0.00116	0.0315	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of Angiotensinogen to Angiotensins—AGT—type 2 diabetes mellitus	0.00112	0.0305	CbGpPWpGaD
Rescinnamine—ACE—ACE Inhibitor Pathway—AGT—type 2 diabetes mellitus	0.00107	0.0291	CbGpPWpGaD
Rescinnamine—ACE—nephron tubule—type 2 diabetes mellitus	0.00103	0.0165	CbGeAlD
Rescinnamine—ACE—cardiovascular system—type 2 diabetes mellitus	0.000927	0.0148	CbGeAlD
Rescinnamine—SLC18A2—Neurotransmitter Release Cycle—GAD2—type 2 diabetes mellitus	0.000911	0.0248	CbGpPWpGaD
Rescinnamine—ACE—kidney—type 2 diabetes mellitus	0.000907	0.0145	CbGeAlD
Rescinnamine—ACE—Peptide hormone metabolism—SLC30A8—type 2 diabetes mellitus	0.000897	0.0245	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—DPP4—type 2 diabetes mellitus	0.000897	0.0245	CbGpPWpGaD
Rescinnamine—ACE—cortex of kidney—type 2 diabetes mellitus	0.000883	0.0141	CbGeAlD
Rescinnamine—ACE—Peptide hormone metabolism—GIP—type 2 diabetes mellitus	0.000864	0.0236	CbGpPWpGaD
Rescinnamine—SLC18A2—liver—type 2 diabetes mellitus	0.00084	0.0134	CbGeAlD
Rescinnamine—ACE—Peptide hormone metabolism—PCSK1—type 2 diabetes mellitus	0.000834	0.0228	CbGpPWpGaD
Rescinnamine—ACE—adipose tissue—type 2 diabetes mellitus	0.000818	0.0131	CbGeAlD
Rescinnamine—ACE—ACE Inhibitor Pathway—NOS3—type 2 diabetes mellitus	0.000782	0.0213	CbGpPWpGaD
Rescinnamine—Reserpine—ABCC2—type 2 diabetes mellitus	0.00078	0.345	CrCbGaD
Rescinnamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A4—type 2 diabetes mellitus	0.000678	0.0185	CbGpPWpGaD
Rescinnamine—Yohimbine—ADRA2A—type 2 diabetes mellitus	0.000622	0.275	CrCbGaD
Rescinnamine—SLC18A2—Neurotransmitter Release Cycle—SNAP25—type 2 diabetes mellitus	0.000587	0.016	CbGpPWpGaD
Rescinnamine—ACE—liver—type 2 diabetes mellitus	0.000573	0.00916	CbGeAlD
Rescinnamine—Yohimbine—HTR2C—type 2 diabetes mellitus	0.000573	0.253	CrCbGaD
Rescinnamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A8—type 2 diabetes mellitus	0.000533	0.0146	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—PAX6—type 2 diabetes mellitus	0.000523	0.0143	CbGpPWpGaD
Rescinnamine—ACE—ACE Inhibitor Pathway—TGFB1—type 2 diabetes mellitus	0.000517	0.0141	CbGpPWpGaD
Rescinnamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A2—type 2 diabetes mellitus	0.000514	0.014	CbGpPWpGaD
Rescinnamine—SLC18A2—Synaptic Vesicle Pathway—SNAP25—type 2 diabetes mellitus	0.000503	0.0137	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—GHRL—type 2 diabetes mellitus	0.000479	0.0131	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.000461	0.0126	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—TCF7L2—type 2 diabetes mellitus	0.000446	0.0122	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—GCG—type 2 diabetes mellitus	0.000438	0.012	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—KCNK16—type 2 diabetes mellitus	0.000436	0.0119	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—GNB3—type 2 diabetes mellitus	0.000378	0.0103	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—PCSK2—type 2 diabetes mellitus	0.000362	0.00987	CbGpPWpGaD
Rescinnamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—type 2 diabetes mellitus	0.000351	0.00957	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—WFS1—type 2 diabetes mellitus	0.000322	0.0088	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.000308	0.0084	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—KCNQ1—type 2 diabetes mellitus	0.000302	0.00825	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.000297	0.00811	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—AGT—type 2 diabetes mellitus	0.000294	0.00802	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—LEP—type 2 diabetes mellitus	0.000288	0.00786	CbGpPWpGaD
Rescinnamine—Yohimbine—CYP3A4—type 2 diabetes mellitus	0.000286	0.127	CrCbGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—GAD2—type 2 diabetes mellitus	0.000261	0.00713	CbGpPWpGaD
Rescinnamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—type 2 diabetes mellitus	0.000261	0.00711	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—INS—type 2 diabetes mellitus	0.000246	0.00672	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.000242	0.00661	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—IGF1—type 2 diabetes mellitus	0.000238	0.0065	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000235	0.0064	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000233	0.00636	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—ABCC8—type 2 diabetes mellitus	0.000229	0.00625	CbGpPWpGaD
Rescinnamine—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000228	0.00179	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Sitagliptin—type 2 diabetes mellitus	0.000226	0.00177	CcSEcCtD
Rescinnamine—Erythema—Gliclazide—type 2 diabetes mellitus	0.000225	0.00177	CcSEcCtD
Rescinnamine—Insomnia—Glimepiride—type 2 diabetes mellitus	0.000225	0.00177	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Irbesartan—type 2 diabetes mellitus	0.000224	0.00177	CcSEcCtD
Rescinnamine—Oedema—Bromocriptine—type 2 diabetes mellitus	0.000224	0.00176	CcSEcCtD
Rescinnamine—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.000224	0.00176	CcSEcCtD
Rescinnamine—Myocardial infarction—Irbesartan—type 2 diabetes mellitus	0.000223	0.00176	CcSEcCtD
Rescinnamine—Paraesthesia—Glimepiride—type 2 diabetes mellitus	0.000223	0.00175	CcSEcCtD
Rescinnamine—Infection—Bromocriptine—type 2 diabetes mellitus	0.000223	0.00175	CcSEcCtD
Rescinnamine—Conjunctivitis—Irbesartan—type 2 diabetes mellitus	0.000221	0.00174	CcSEcCtD
Rescinnamine—Urinary tract infection—Irbesartan—type 2 diabetes mellitus	0.000221	0.00174	CcSEcCtD
Rescinnamine—Nausea—Nateglinide—type 2 diabetes mellitus	0.000221	0.00174	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Losartan—type 2 diabetes mellitus	0.000219	0.00173	CcSEcCtD
Rescinnamine—Back pain—Gliclazide—type 2 diabetes mellitus	0.000218	0.00171	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.000218	0.00171	CcSEcCtD
Rescinnamine—Rhinitis—Metformin—type 2 diabetes mellitus	0.000217	0.00171	CcSEcCtD
Rescinnamine—SLC18A2—Dopaminergic Neurogenesis—TGFB1—type 2 diabetes mellitus	0.000217	0.00592	CbGpPWpGaD
Rescinnamine—Hypoaesthesia—Metformin—type 2 diabetes mellitus	0.000216	0.0017	CcSEcCtD
Rescinnamine—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000215	0.00169	CcSEcCtD
Rescinnamine—Myalgia—Glyburide—type 2 diabetes mellitus	0.000214	0.00168	CcSEcCtD
Rescinnamine—Pain—Sitagliptin—type 2 diabetes mellitus	0.000212	0.00167	CcSEcCtD
Rescinnamine—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000212	0.00167	CcSEcCtD
Rescinnamine—Urticaria—Glipizide—type 2 diabetes mellitus	0.000211	0.00166	CcSEcCtD
Rescinnamine—Gastritis—Ramipril—type 2 diabetes mellitus	0.000211	0.00166	CcSEcCtD
Rescinnamine—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.00021	0.00165	CcSEcCtD
Rescinnamine—Conjunctivitis—Losartan—type 2 diabetes mellitus	0.000208	0.00164	CcSEcCtD
Rescinnamine—Urinary tract infection—Losartan—type 2 diabetes mellitus	0.000208	0.00164	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—ADAMTS9—type 2 diabetes mellitus	0.000208	0.00567	CbGpPWpGaD
Rescinnamine—Influenza—Ramipril—type 2 diabetes mellitus	0.000206	0.00162	CcSEcCtD
Rescinnamine—Rhinitis—Irbesartan—type 2 diabetes mellitus	0.000205	0.00161	CcSEcCtD
Rescinnamine—Oedema—Glyburide—type 2 diabetes mellitus	0.000205	0.00161	CcSEcCtD
Rescinnamine—Hypoaesthesia—Irbesartan—type 2 diabetes mellitus	0.000203	0.0016	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000203	0.0016	CcSEcCtD
Rescinnamine—Pharyngitis—Irbesartan—type 2 diabetes mellitus	0.000203	0.0016	CcSEcCtD
Rescinnamine—Rash—Repaglinide—type 2 diabetes mellitus	0.000203	0.0016	CcSEcCtD
Rescinnamine—Dysgeusia—Valsartan—type 2 diabetes mellitus	0.000203	0.00159	CcSEcCtD
Rescinnamine—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000203	0.00159	CcSEcCtD
Rescinnamine—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000203	0.00159	CcSEcCtD
Rescinnamine—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000203	0.00159	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000202	0.00159	CcSEcCtD
Rescinnamine—Headache—Repaglinide—type 2 diabetes mellitus	0.000202	0.00159	CcSEcCtD
Rescinnamine—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.000201	0.00158	CcSEcCtD
Rescinnamine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000201	0.00158	CcSEcCtD
Rescinnamine—Sinusitis—Losartan—type 2 diabetes mellitus	0.000201	0.00158	CcSEcCtD
Rescinnamine—Angina pectoris—Ramipril—type 2 diabetes mellitus	0.000201	0.00158	CcSEcCtD
Rescinnamine—Dysgeusia—Orlistat—type 2 diabetes mellitus	0.0002	0.00158	CcSEcCtD
Rescinnamine—Back pain—Valsartan—type 2 diabetes mellitus	0.0002	0.00158	CcSEcCtD
Rescinnamine—SLC18A2—Neuronal System—GAD2—type 2 diabetes mellitus	0.0002	0.00546	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000198	0.00541	CbGpPWpGaD
Rescinnamine—Bronchitis—Ramipril—type 2 diabetes mellitus	0.000198	0.00156	CcSEcCtD
Rescinnamine—Back pain—Orlistat—type 2 diabetes mellitus	0.000198	0.00156	CcSEcCtD
Rescinnamine—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000197	0.00155	CcSEcCtD
Rescinnamine—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000197	0.00155	CcSEcCtD
Rescinnamine—Cough—Gliclazide—type 2 diabetes mellitus	0.000197	0.00155	CcSEcCtD
Rescinnamine—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000196	0.00154	CcSEcCtD
Rescinnamine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000196	0.00154	CcSEcCtD
Rescinnamine—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000196	0.00154	CcSEcCtD
Rescinnamine—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000195	0.00153	CcSEcCtD
Rescinnamine—Rhinitis—Losartan—type 2 diabetes mellitus	0.000193	0.00152	CcSEcCtD
Rescinnamine—Myalgia—Gliclazide—type 2 diabetes mellitus	0.000192	0.00151	CcSEcCtD
Rescinnamine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000192	0.00151	CcSEcCtD
Rescinnamine—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000192	0.00151	CcSEcCtD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000192	0.00523	CbGpPWpGaD
Rescinnamine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000192	0.00151	CcSEcCtD
Rescinnamine—Hypoaesthesia—Losartan—type 2 diabetes mellitus	0.000191	0.00151	CcSEcCtD
Rescinnamine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000191	0.0015	CcSEcCtD
Rescinnamine—Pharyngitis—Losartan—type 2 diabetes mellitus	0.000191	0.0015	CcSEcCtD
Rescinnamine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00019	0.0015	CcSEcCtD
Rescinnamine—Discomfort—Gliclazide—type 2 diabetes mellitus	0.00019	0.00149	CcSEcCtD
Rescinnamine—Erythema—Metformin—type 2 diabetes mellitus	0.000189	0.00148	CcSEcCtD
Rescinnamine—Pruritus—Glipizide—type 2 diabetes mellitus	0.000188	0.00148	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Ramipril—type 2 diabetes mellitus	0.000188	0.00148	CcSEcCtD
Rescinnamine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000188	0.00148	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000187	0.00147	CcSEcCtD
Rescinnamine—Dysgeusia—Metformin—type 2 diabetes mellitus	0.000185	0.00145	CcSEcCtD
Rescinnamine—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000184	0.00145	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000183	0.00144	CcSEcCtD
Rescinnamine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000183	0.00144	CcSEcCtD
Rescinnamine—Infection—Gliclazide—type 2 diabetes mellitus	0.000183	0.00144	CcSEcCtD
Rescinnamine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000182	0.00143	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Ramipril—type 2 diabetes mellitus	0.000181	0.00142	CcSEcCtD
Rescinnamine—SLC18A2—Neuronal System—KCNJ11—type 2 diabetes mellitus	0.000181	0.00494	CbGpPWpGaD
Rescinnamine—Cough—Valsartan—type 2 diabetes mellitus	0.000181	0.00142	CcSEcCtD
Rescinnamine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000181	0.00142	CcSEcCtD
Rescinnamine—Myocardial infarction—Ramipril—type 2 diabetes mellitus	0.00018	0.00142	CcSEcCtD
Rescinnamine—Conjunctivitis—Ramipril—type 2 diabetes mellitus	0.000179	0.0014	CcSEcCtD
Rescinnamine—Urinary tract infection—Ramipril—type 2 diabetes mellitus	0.000179	0.0014	CcSEcCtD
Rescinnamine—Cough—Orlistat—type 2 diabetes mellitus	0.000179	0.0014	CcSEcCtD
Rescinnamine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000178	0.0014	CcSEcCtD
Rescinnamine—Erythema—Irbesartan—type 2 diabetes mellitus	0.000178	0.0014	CcSEcCtD
Rescinnamine—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000177	0.00139	CcSEcCtD
Rescinnamine—Myalgia—Valsartan—type 2 diabetes mellitus	0.000176	0.00139	CcSEcCtD
Rescinnamine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000176	0.00138	CcSEcCtD
Rescinnamine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000176	0.00138	CcSEcCtD
Rescinnamine—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000174	0.00137	CcSEcCtD
Rescinnamine—Myalgia—Orlistat—type 2 diabetes mellitus	0.000174	0.00137	CcSEcCtD
Rescinnamine—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000172	0.00136	CcSEcCtD
Rescinnamine—Discomfort—Orlistat—type 2 diabetes mellitus	0.000172	0.00135	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—SLC30A8—type 2 diabetes mellitus	0.000169	0.00462	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—DPP4—type 2 diabetes mellitus	0.000169	0.00462	CbGpPWpGaD
Rescinnamine—Oedema—Valsartan—type 2 diabetes mellitus	0.000169	0.00133	CcSEcCtD
Rescinnamine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000169	0.00133	CcSEcCtD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—SNAP25—type 2 diabetes mellitus	0.000168	0.00459	CbGpPWpGaD
Rescinnamine—Infection—Valsartan—type 2 diabetes mellitus	0.000168	0.00132	CcSEcCtD
Rescinnamine—Rash—Glipizide—type 2 diabetes mellitus	0.000168	0.00132	CcSEcCtD
Rescinnamine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000168	0.00132	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000168	0.00132	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000168	0.00132	CcSEcCtD
Rescinnamine—Erythema—Losartan—type 2 diabetes mellitus	0.000167	0.00132	CcSEcCtD
Rescinnamine—Oedema—Orlistat—type 2 diabetes mellitus	0.000167	0.00131	CcSEcCtD
Rescinnamine—Headache—Glipizide—type 2 diabetes mellitus	0.000167	0.00131	CcSEcCtD
Rescinnamine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000166	0.00131	CcSEcCtD
Rescinnamine—Infection—Orlistat—type 2 diabetes mellitus	0.000166	0.0013	CcSEcCtD
Rescinnamine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000165	0.0013	CcSEcCtD
Rescinnamine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000164	0.00129	CcSEcCtD
Rescinnamine—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000164	0.00129	CcSEcCtD
Rescinnamine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000164	0.00129	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—GIP—type 2 diabetes mellitus	0.000163	0.00445	CbGpPWpGaD
Rescinnamine—Hypertension—Metformin—type 2 diabetes mellitus	0.000163	0.00128	CcSEcCtD
Rescinnamine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000163	0.00128	CcSEcCtD
Rescinnamine—Back pain—Losartan—type 2 diabetes mellitus	0.000162	0.00127	CcSEcCtD
Rescinnamine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000162	0.00127	CcSEcCtD
Rescinnamine—Myalgia—Metformin—type 2 diabetes mellitus	0.000161	0.00126	CcSEcCtD
Rescinnamine—Headache—Pioglitazone—type 2 diabetes mellitus	0.00016	0.00126	CcSEcCtD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.000159	0.00435	CbGpPWpGaD
Rescinnamine—Discomfort—Metformin—type 2 diabetes mellitus	0.000159	0.00125	CcSEcCtD
Rescinnamine—Nausea—Glipizide—type 2 diabetes mellitus	0.000158	0.00124	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—PCSK1—type 2 diabetes mellitus	0.000157	0.0043	CbGpPWpGaD
Rescinnamine—Pain—Gliclazide—type 2 diabetes mellitus	0.000157	0.00124	CcSEcCtD
Rescinnamine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000157	0.00124	CcSEcCtD
Rescinnamine—Rash—Glimepiride—type 2 diabetes mellitus	0.000157	0.00123	CcSEcCtD
Rescinnamine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000156	0.00123	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000156	0.00427	CbGpPWpGaD
Rescinnamine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000156	0.00123	CcSEcCtD
Rescinnamine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000156	0.00123	CcSEcCtD
Rescinnamine—Headache—Glimepiride—type 2 diabetes mellitus	0.000156	0.00122	CcSEcCtD
Rescinnamine—Cough—Irbesartan—type 2 diabetes mellitus	0.000155	0.00122	CcSEcCtD
Rescinnamine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000155	0.00122	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000154	0.00121	CcSEcCtD
Rescinnamine—Oedema—Metformin—type 2 diabetes mellitus	0.000154	0.00121	CcSEcCtD
Rescinnamine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000154	0.00121	CcSEcCtD
Rescinnamine—Infection—Metformin—type 2 diabetes mellitus	0.000153	0.0012	CcSEcCtD
Rescinnamine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000153	0.0012	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—ST6GAL1—type 2 diabetes mellitus	0.000153	0.00416	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.000152	0.00415	CbGpPWpGaD
Rescinnamine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000152	0.0012	CcSEcCtD
Rescinnamine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000152	0.00119	CcSEcCtD
Rescinnamine—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000152	0.00119	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000151	0.00412	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000151	0.00412	CbGpPWpGaD
Rescinnamine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000151	0.00119	CcSEcCtD
Rescinnamine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000151	0.00119	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.00015	0.00118	CcSEcCtD
Rescinnamine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.00015	0.00118	CcSEcCtD
Rescinnamine—Discomfort—Irbesartan—type 2 diabetes mellitus	0.00015	0.00118	CcSEcCtD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.000149	0.00405	CbGpPWpGaD
Rescinnamine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000148	0.00117	CcSEcCtD
Rescinnamine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000148	0.00116	CcSEcCtD
Rescinnamine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000147	0.00116	CcSEcCtD
Rescinnamine—Cough—Losartan—type 2 diabetes mellitus	0.000146	0.00115	CcSEcCtD
Rescinnamine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000146	0.00115	CcSEcCtD
Rescinnamine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000145	0.00114	CcSEcCtD
Rescinnamine—Oedema—Irbesartan—type 2 diabetes mellitus	0.000145	0.00114	CcSEcCtD
Rescinnamine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000145	0.00114	CcSEcCtD
Rescinnamine—Constipation—Valsartan—type 2 diabetes mellitus	0.000145	0.00114	CcSEcCtD
Rescinnamine—Infection—Irbesartan—type 2 diabetes mellitus	0.000144	0.00113	CcSEcCtD
Rescinnamine—Erythema—Ramipril—type 2 diabetes mellitus	0.000144	0.00113	CcSEcCtD
Rescinnamine—Pain—Orlistat—type 2 diabetes mellitus	0.000143	0.00112	CcSEcCtD
Rescinnamine—Myalgia—Losartan—type 2 diabetes mellitus	0.000143	0.00112	CcSEcCtD
Rescinnamine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000141	0.00111	CcSEcCtD
Rescinnamine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000141	0.00111	CcSEcCtD
Rescinnamine—Discomfort—Losartan—type 2 diabetes mellitus	0.000141	0.00111	CcSEcCtD
Rescinnamine—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000141	0.00111	CcSEcCtD
Rescinnamine—Headache—Bromocriptine—type 2 diabetes mellitus	0.00014	0.0011	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.00014	0.0011	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000138	0.00377	CbGpPWpGaD
Rescinnamine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000138	0.00109	CcSEcCtD
Rescinnamine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000138	0.00109	CcSEcCtD
Rescinnamine—Oedema—Losartan—type 2 diabetes mellitus	0.000137	0.00108	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000137	0.00107	CcSEcCtD
Rescinnamine—Infection—Losartan—type 2 diabetes mellitus	0.000136	0.00107	CcSEcCtD
Rescinnamine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000136	0.00107	CcSEcCtD
Rescinnamine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000134	0.00106	CcSEcCtD
Rescinnamine—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000134	0.00105	CcSEcCtD
Rescinnamine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000133	0.00105	CcSEcCtD
Rescinnamine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000133	0.00104	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000132	0.00104	CcSEcCtD
Rescinnamine—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000132	0.00104	CcSEcCtD
Rescinnamine—Constipation—Metformin—type 2 diabetes mellitus	0.000132	0.00104	CcSEcCtD
Rescinnamine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.00013	0.00103	CcSEcCtD
Rescinnamine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00013	0.00102	CcSEcCtD
Rescinnamine—Rash—Glyburide—type 2 diabetes mellitus	0.000129	0.00102	CcSEcCtD
Rescinnamine—SLC18A2—Neuronal System—SNAP25—type 2 diabetes mellitus	0.000129	0.00352	CbGpPWpGaD
Rescinnamine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000129	0.00101	CcSEcCtD
Rescinnamine—Headache—Glyburide—type 2 diabetes mellitus	0.000128	0.00101	CcSEcCtD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	0.000126	0.00343	CbGpPWpGaD
Rescinnamine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000126	0.00099	CcSEcCtD
Rescinnamine—Cough—Ramipril—type 2 diabetes mellitus	0.000125	0.000986	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000125	0.000979	CcSEcCtD
Rescinnamine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000125	0.000979	CcSEcCtD
Rescinnamine—Pain—Irbesartan—type 2 diabetes mellitus	0.000124	0.000977	CcSEcCtD
Rescinnamine—Constipation—Irbesartan—type 2 diabetes mellitus	0.000124	0.000977	CcSEcCtD
Rescinnamine—Insomnia—Losartan—type 2 diabetes mellitus	0.000124	0.000972	CcSEcCtD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	0.000123	0.00337	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000123	0.00336	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000123	0.00336	CbGpPWpGaD
Rescinnamine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000123	0.000968	CcSEcCtD
Rescinnamine—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000123	0.000965	CcSEcCtD
Rescinnamine—Urticaria—Metformin—type 2 diabetes mellitus	0.000122	0.000962	CcSEcCtD
Rescinnamine—Myalgia—Ramipril—type 2 diabetes mellitus	0.000122	0.000962	CcSEcCtD
Rescinnamine—Nausea—Glyburide—type 2 diabetes mellitus	0.000122	0.000957	CcSEcCtD
Rescinnamine—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000122	0.000957	CcSEcCtD
Rescinnamine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000122	0.000957	CcSEcCtD
Rescinnamine—Discomfort—Ramipril—type 2 diabetes mellitus	0.000121	0.00095	CcSEcCtD
Rescinnamine—Pruritus—Valsartan—type 2 diabetes mellitus	0.00012	0.00094	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000119	0.000934	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000119	0.00323	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000119	0.00323	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	0.000118	0.00323	CbGpPWpGaD
Rescinnamine—Pruritus—Orlistat—type 2 diabetes mellitus	0.000118	0.000929	CcSEcCtD
Rescinnamine—Oedema—Ramipril—type 2 diabetes mellitus	0.000117	0.000922	CcSEcCtD
Rescinnamine—Pain—Losartan—type 2 diabetes mellitus	0.000117	0.000919	CcSEcCtD
Rescinnamine—Constipation—Losartan—type 2 diabetes mellitus	0.000117	0.000919	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000116	0.00318	CbGpPWpGaD
Rescinnamine—Rash—Gliclazide—type 2 diabetes mellitus	0.000116	0.000912	CcSEcCtD
Rescinnamine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000116	0.000911	CcSEcCtD
Rescinnamine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000115	0.000907	CcSEcCtD
Rescinnamine—Headache—Gliclazide—type 2 diabetes mellitus	0.000115	0.000906	CcSEcCtD
Rescinnamine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000115	0.000903	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—ATF3—type 2 diabetes mellitus	0.000113	0.00308	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.000112	0.00306	CbGpPWpGaD
Rescinnamine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000112	0.000879	CcSEcCtD
Rescinnamine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000112	0.000879	CcSEcCtD
Rescinnamine—Dizziness—Orlistat—type 2 diabetes mellitus	0.00011	0.000869	CcSEcCtD
Rescinnamine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000109	0.000859	CcSEcCtD
Rescinnamine—Pruritus—Metformin—type 2 diabetes mellitus	0.000109	0.000856	CcSEcCtD
Rescinnamine—Urticaria—Losartan—type 2 diabetes mellitus	0.000109	0.000854	CcSEcCtD
Rescinnamine—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000108	0.00085	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000108	0.00294	CbGpPWpGaD
Rescinnamine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000107	0.000842	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000107	0.00084	CcSEcCtD
Rescinnamine—Rash—Valsartan—type 2 diabetes mellitus	0.000107	0.000838	CcSEcCtD
Rescinnamine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000106	0.000837	CcSEcCtD
Rescinnamine—Insomnia—Ramipril—type 2 diabetes mellitus	0.000106	0.000834	CcSEcCtD
Rescinnamine—Headache—Valsartan—type 2 diabetes mellitus	0.000106	0.000833	CcSEcCtD
Rescinnamine—Rash—Orlistat—type 2 diabetes mellitus	0.000105	0.000828	CcSEcCtD
Rescinnamine—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000105	0.000828	CcSEcCtD
Rescinnamine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000105	0.000827	CcSEcCtD
Rescinnamine—Headache—Orlistat—type 2 diabetes mellitus	0.000105	0.000823	CcSEcCtD
Rescinnamine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000103	0.000808	CcSEcCtD
Rescinnamine—Dizziness—Metformin—type 2 diabetes mellitus	0.000102	0.0008	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—F7—type 2 diabetes mellitus	0.000101	0.00277	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000101	0.00275	CbGpPWpGaD
Rescinnamine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000101	0.000792	CcSEcCtD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	0.000101	0.00275	CbGpPWpGaD
Rescinnamine—Nausea—Valsartan—type 2 diabetes mellitus	0.0001	0.00079	CcSEcCtD
Rescinnamine—Constipation—Ramipril—type 2 diabetes mellitus	0.0001	0.000788	CcSEcCtD
Rescinnamine—Nausea—Orlistat—type 2 diabetes mellitus	9.92e-05	0.00078	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—PAX6—type 2 diabetes mellitus	9.88e-05	0.00269	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	9.74e-05	0.00266	CbGpPWpGaD
Rescinnamine—Rash—Metformin—type 2 diabetes mellitus	9.7e-05	0.000763	CcSEcCtD
Rescinnamine—Dermatitis—Metformin—type 2 diabetes mellitus	9.69e-05	0.000762	CcSEcCtD
Rescinnamine—Pruritus—Losartan—type 2 diabetes mellitus	9.67e-05	0.000761	CcSEcCtD
Rescinnamine—SLC18A2—Neuronal System—GNB3—type 2 diabetes mellitus	9.64e-05	0.00263	CbGpPWpGaD
Rescinnamine—Headache—Metformin—type 2 diabetes mellitus	9.64e-05	0.000758	CcSEcCtD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	9.64e-05	0.00263	CbGpPWpGaD
Rescinnamine—Dizziness—Irbesartan—type 2 diabetes mellitus	9.6e-05	0.000755	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	9.58e-05	0.000754	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	9.34e-05	0.00255	CbGpPWpGaD
Rescinnamine—Urticaria—Ramipril—type 2 diabetes mellitus	9.31e-05	0.000732	CcSEcCtD
Rescinnamine—Abdominal pain—Ramipril—type 2 diabetes mellitus	9.26e-05	0.000729	CcSEcCtD
Rescinnamine—Rash—Irbesartan—type 2 diabetes mellitus	9.16e-05	0.00072	CcSEcCtD
Rescinnamine—Dermatitis—Irbesartan—type 2 diabetes mellitus	9.15e-05	0.00072	CcSEcCtD
Rescinnamine—Nausea—Metformin—type 2 diabetes mellitus	9.14e-05	0.000719	CcSEcCtD
Rescinnamine—Headache—Irbesartan—type 2 diabetes mellitus	9.1e-05	0.000716	CcSEcCtD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	9.06e-05	0.00247	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—GHRL—type 2 diabetes mellitus	9.05e-05	0.00247	CbGpPWpGaD
Rescinnamine—Dizziness—Losartan—type 2 diabetes mellitus	9.04e-05	0.000711	CcSEcCtD
Rescinnamine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	8.63e-05	0.000679	CcSEcCtD
Rescinnamine—Nausea—Irbesartan—type 2 diabetes mellitus	8.63e-05	0.000679	CcSEcCtD
Rescinnamine—Rash—Losartan—type 2 diabetes mellitus	8.62e-05	0.000678	CcSEcCtD
Rescinnamine—Dermatitis—Losartan—type 2 diabetes mellitus	8.61e-05	0.000677	CcSEcCtD
Rescinnamine—SLC18A2—Neuronal System—ADCY5—type 2 diabetes mellitus	8.6e-05	0.00234	CbGpPWpGaD
Rescinnamine—Headache—Losartan—type 2 diabetes mellitus	8.56e-05	0.000673	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—TCF7L2—type 2 diabetes mellitus	8.41e-05	0.0023	CbGpPWpGaD
Rescinnamine—Pruritus—Ramipril—type 2 diabetes mellitus	8.29e-05	0.000652	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—GCG—type 2 diabetes mellitus	8.27e-05	0.00226	CbGpPWpGaD
Rescinnamine—Nausea—Losartan—type 2 diabetes mellitus	8.12e-05	0.000639	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	8.1e-05	0.00221	CbGpPWpGaD
Rescinnamine—Dizziness—Ramipril—type 2 diabetes mellitus	7.75e-05	0.00061	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	7.74e-05	0.00211	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	7.74e-05	0.00211	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	7.55e-05	0.00206	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	7.51e-05	0.00205	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	7.46e-05	0.00204	CbGpPWpGaD
Rescinnamine—Rash—Ramipril—type 2 diabetes mellitus	7.39e-05	0.000581	CcSEcCtD
Rescinnamine—SLC18A2—Neuronal System—CALM1—type 2 diabetes mellitus	7.39e-05	0.00201	CbGpPWpGaD
Rescinnamine—Dermatitis—Ramipril—type 2 diabetes mellitus	7.38e-05	0.000581	CcSEcCtD
Rescinnamine—Headache—Ramipril—type 2 diabetes mellitus	7.34e-05	0.000577	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—GNB3—type 2 diabetes mellitus	7.13e-05	0.00194	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—IGF2—type 2 diabetes mellitus	7e-05	0.00191	CbGpPWpGaD
Rescinnamine—Nausea—Ramipril—type 2 diabetes mellitus	6.96e-05	0.000548	CcSEcCtD
Rescinnamine—SLC18A2—Neuronal System—PRKCB—type 2 diabetes mellitus	6.94e-05	0.00189	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	6.58e-05	0.00179	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	6.28e-05	0.00171	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	6.1e-05	0.00166	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	6.02e-05	0.00164	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—MMP1—type 2 diabetes mellitus	5.62e-05	0.00153	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—AGT—type 2 diabetes mellitus	5.55e-05	0.00151	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—LEP—type 2 diabetes mellitus	5.44e-05	0.00148	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	5.19e-05	0.00141	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	5.16e-05	0.00141	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	5.12e-05	0.0014	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	4.94e-05	0.00135	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—INS—type 2 diabetes mellitus	4.65e-05	0.00127	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	4.62e-05	0.00126	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—CCL2—type 2 diabetes mellitus	4.57e-05	0.00125	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—IGF1—type 2 diabetes mellitus	4.5e-05	0.00123	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	4.17e-05	0.00114	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	3.91e-05	0.00107	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.1e-05	0.000845	CbGpPWpGaD
